Tagged dravet-syndrome

Health Canada Grants No Objection Letter to Epygenix Therapeutics to Proceed With ARGUS Trial for the Treatment of Dravet Syndrome
Press Release

Health Canada Grants No Objection Letter to Epygenix Therapeutics to Proceed With ARGUS Trial for the Treatment of Dravet Syndrome

 Read More
Epygenix Therapeutics Receives Orphan Medicinal Product Designation in Europe With EPX-200 for the Treatment of Patients With Dravet Syndrome
Press Release

Epygenix Therapeutics Receives Orphan Medicinal Product Designation in Europe With EPX-200 for the Treatment of Patients With Dravet Syndrome

 Read More
Epygenix Therapeutics Announces First Patient Successfully Dosed in Phase 2 Study for the Treatment of Dravet Syndrome With EPX-100
Press Release

Epygenix Therapeutics Announces First Patient Successfully Dosed in Phase 2 Study for the Treatment of Dravet Syndrome With EPX-100

 Read More
Epygenix Therapeutics Announces First Patient Enrolled in Phase 2 Study for the Treatment of Dravet Syndrome With EPX-100
Press Release

Epygenix Therapeutics Announces First Patient Enrolled in Phase 2 Study for the Treatment of Dravet Syndrome With EPX-100

 Read More
Epygenix Therapeutics Initiates Phase 2 Study for Dravet Syndrome With EPX-100
Press Release

Epygenix Therapeutics Initiates Phase 2 Study for Dravet Syndrome With EPX-100

 Read More
Epygenix Therapeutics Successfully Completes EPX-100 Phase I, Placebo-Controlled, Double-Blind, 2-Period Study and Ready to Phase 2 Studies
Press Release

Epygenix Therapeutics Successfully Completes EPX-100 Phase I, Placebo-Controlled, Double-Blind, 2-Period Study and Ready to Phase 2 Studies

 Read More
New Small Molecule to Treat Alzheimer's Disease and Dravet Syndrome
Press Release

New Small Molecule to Treat Alzheimer's Disease and Dravet Syndrome

 New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome. Read More
Press Release

Families Dedicated to Conquering Rare Epilepsies Join Efforts to Improve Treatment Options

 Two-part Nov. 1, 2019 meeting will highlight unmet needs and treatment expectations Read More
Press Release

Epygenix Therapeutics Receives IND Approval of EPX-100 for the Treatment of Dravet Syndrome

 Dravet Syndrome, a catastrophic form of epilepsy, affects one in 15,700 children and adults in the United States. Read More
Epygenix Therapeutics Submits Investigational New Drug Application for EPX-100 to the U.S. FDA for the Treatment of Patients With Dravet Syndrome
Press Release

Epygenix Therapeutics Submits Investigational New Drug Application for EPX-100 to the U.S. FDA for the Treatment of Patients With Dravet Syndrome

 Read More
Two Possible New Ways to Treat Silent Seizures in Children
Press Release

Two Possible New Ways to Treat Silent Seizures in Children

 An unexpected brain region is important for Dravet Syndrome, finds study from the Gladstone Institutes Read More
Press Release

A New Research Partnership to Find Treatments for Neurological Disorders

 BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders Read More
Press Release

First Prescription Formulation of Cannabidiol (CBD) Approved for Lennox-Gastaut Syndrome

 Read More
Epygenix Therapeutics Receives US FDA Orphan Drug Designation for EPX-300 for the Treatment of Patients With Dravet Syndrome
Press Release

Epygenix Therapeutics Receives US FDA Orphan Drug Designation for EPX-300 for the Treatment of Patients With Dravet Syndrome

 Dravet Syndrome is a catastrophic form of epilepsy, affecting one in 15,700 children and adults in the United States. Read More
Epygenix Therapeutics Receives Orphan Drug Designation From the U.S. FDA for EPX-100 and EPX-200 in the Treatment of Patients With Dravet Syndrome
Press Release

Epygenix Therapeutics Receives Orphan Drug Designation From the U.S. FDA for EPX-100 and EPX-200 in the Treatment of Patients With Dravet Syndrome

 Dravet Syndrome, a catastrophic form of epilepsy, affects one in 15,700 children and adults in the United States. Read More
CBD Vape Pens Now Available on Groupon
Press Release

CBD Vape Pens Now Available on Groupon

 Read More